CN111388741B - Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof - Google Patents

Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof Download PDF

Info

Publication number
CN111388741B
CN111388741B CN202010250210.1A CN202010250210A CN111388741B CN 111388741 B CN111388741 B CN 111388741B CN 202010250210 A CN202010250210 A CN 202010250210A CN 111388741 B CN111388741 B CN 111388741B
Authority
CN
China
Prior art keywords
dextran
polypeptide
preloaded
solution
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010250210.1A
Other languages
Chinese (zh)
Other versions
CN111388741A (en
Inventor
吴德群
叶婷婷
刘畅
王学利
李发学
俞建勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN202010250210.1A priority Critical patent/CN111388741B/en
Publication of CN111388741A publication Critical patent/CN111388741A/en
Application granted granted Critical
Publication of CN111388741B publication Critical patent/CN111388741B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/62Compostable, hydrosoluble or hydrodegradable materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/009Materials resorbable by the body
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention discloses an injectable self-repairing antibacterial hydrogel dressing with preloaded polypeptide and a preparation method thereof. The hydrogel dressing comprises a hydrogel bound to a fabric, the hydrogel having polypeptides distributed on and within its surface that promote migration of fibroblasts. The preparation method comprises the following steps: selectively oxidizing glucans with different molecular weights into aldehyde group glucan by an oxidant; reacting aldehyde dextran with fatty amine to obtain partially alkylated dextran; then preparing polypeptide in solid phase; the preparation method comprises the steps of respectively dissolving aldehyde dextran, adipic dihydrazide and partially alkylated dextran in a PBS buffer solution, adding the polypeptide into the aldehyde dextran solution, preloading the polypeptide synthesized by a solid phase, mixing the three solutions according to a certain mass ratio, preparing the injectable self-repairing antibacterial hydrogel of preloaded polypeptide, and finally preparing the dressing. The product prepared by the invention has good antibacterial performance, can reduce the infection chance of wounds, has dynamic self-repairing performance, can aim at irregular wounds, can keep the wound surfaces moist and accelerate the wound healing.

Description

Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof
Technical Field
The invention relates to an injectable dynamic self-repairing antibacterial hydrogel dressing preloaded with polypeptides and a preparation method thereof, and belongs to the technical field of medical materials and preparation thereof.
Background
Wound healing is a complex and coordinated process involving hemostasis, inflammation, cell proliferation and extracellular matrix remodeling. Currently, bacterial infection and poor wound healing rates remain major challenges in wound therapy. Bacterial infection often results in the formation of exudates, which greatly impedes wound healing. In addition, chronic wounds and deep wounds are often difficult to vascularize and self-repair due to reduced activity of endogenous growth factors. To overcome these problems, many wound dressing materials such as films, hydrogels, foams and hydrocolloids have been developed to meet the requirements of preventing infection and accelerating wound closure. Among these materials, injectable hydrogels are a potential dressing due to their excellent properties, including encapsulation of cells or drugs, filling of irregular wound sites, and adequate adhesion to wounds.
Conventional injectable hydrogels are vulnerable to external forces during clinical treatment, especially for irregular and deep wound sites, due to their lack of self-healing capabilities, and are thus not conducive to wound repair. As an improvement, the self-repairing hydrogel can automatically repair the broken hydrogel in an active state by generating dynamic covalent bonds and non-covalent bonds, thereby prolonging the service time of the hydrogel, reducing the times of dressing change and being beneficial to the healing of irregular wounds. Dynamic covalent bonds, such as disulfide bonds, imine bonds (schiff bases), phenylboronate, acylhydrazone bonds and Diels-Alder reactions, exhibit unique advantages in the construction of self-healing hydrogels due to their excellent reversibility and stability. Thus, for irregular wound sites, self-healing hydrogels not only facilitate wound healing and tissue repair, but also can encapsulate different drugs to control delivery.
Polypeptide-based wound dressings have great potential in meeting medical needs due to their high specificity, effectiveness, and safety. The present invention utilizes solid phase synthesis to prepare novel polypeptides. The preloaded polypeptide contains KGRT sequence, is derived from the functional region of erythroid differentiation regulating factor 1(Erdr1), shares three amino acids with erythroid differentiation regulating factor 1(Erdr1), and can regulate stress related reaction. The preloaded novel polypeptides can stimulate wound healing by promoting fibroblast, keratinocyte and vascular endothelial cell migration and tissue infiltration. As a material of biological origin, glucan has been proved to have excellent biocompatibility and biodegradability and can be used as a self-repairing biomaterial for promoting wound healing.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: how to improve the tissue adhesion capability of glucan by modifying glucan.
In order to solve the technical problems, the invention provides an injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptides, which is characterized by comprising a hydrogel combined with a fabric, wherein polypeptides for promoting migration of fiber cells are distributed on the surface and inside the hydrogel; the hydrogel is prepared by respectively dissolving aldehyde dextran, dihydrazide and partially alkylated dextran in PBS solution, mixing and crosslinking.
Preferably, the polypeptide contains a KGRT sequence, is derived from erythroid differentiation regulating factor 1, namely a functional region of Erdr1, and shares three amino acids with Erdr1, wherein Erdr1 can regulate stress-related reactions.
The invention also provides a preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide, which is characterized by comprising the following steps:
step 1): selectively oxidizing glucans with different molecular weights into aldehyde group glucan by an oxidant;
step 2): reacting the aldehyde dextran with fatty amine to obtain partially alkylated dextran;
step 3): solid phase preparation of polypeptide:
step 3.1): adding dichlorotrityl chloride resin into a solvent for soaking, fully swelling the resin, and then discharging the solvent;
step 3.2): dissolving amino acid with solvent, transferring the solution into treated dichloro trityl chloride resin, adding catalyst, and allowing the amino acid and resin to interact at room temperature to fix on the resin;
step 3.3): washing the resin with a solvent, adding a piperidine solution into the resin for reaction, and removing a protecting group;
step 3.4): the resin was washed with solvent and checked for complete protection with ninhydrin;
step 3.5): dissolving amino acid, HBTU and HOBt in a solvent, transferring the solution into the resin obtained in the step 3.4), adding a catalyst, and reacting at room temperature; washing the resin with a solvent, checking whether the amino group is completely reacted with ninhydrin, and carrying out the next step if the amino group is colorless; if the color is blue, repeating the step until the color is detected to be colorless, and synthesizing the polypeptide;
step 3.6): washing the resin with dichloromethane, fully washing to dry, and then drying;
step 3.7): reacting trifluoroacetic acid with the product obtained in the step 3.6) to cut off polypeptide;
step 3.8): collecting filtrate and washing liquid, performing rotary evaporation and concentration, precipitating with anhydrous ether, and standing; after the precipitation is sufficient, carrying out suction filtration, washing and drying;
step 4): dissolving the aldehyde dextran obtained in the step 1), adipic acid dihydrazide and the partially alkylated dextran obtained in the step 2) in a PBS buffer solution respectively, adding the polypeptide prepared in the step 3) into the aldehyde dextran solution, preloading the polypeptide synthesized in a solid phase, and then mixing the three solutions to prepare the injectable self-repairing antibacterial hydrogel preloaded with the polypeptide;
step 5): the injectable self-repairing antibacterial hydrogel preloaded with the polypeptide is combined with the fabric to prepare the dressing.
Preferably, the number average molecular weight of the glucan in the step 1) is 5000-100000; the oxidant is KMnO4,NaIO4Or KIO4
Preferably, the number of carbon atoms of the aliphatic amine in the step 2) is 6-15.
Preferably, the step 2) is specifically: dissolving aldehyde dextran in deionized water at room temperature, dissolving fatty amine in ethanol solution, mixing the two solutions, and reacting for 1-4 hours; adding excessive sodium cyanoborohydride into the mixed solution, stirring at room temperature for 12-24 hours, and precipitating part of alkylated glucan by using ethanol; and dialyzing, freeze-drying and storing the reaction product.
More preferably, the molar ratio of sodium cyanoborohydride to aldehydized dextran is 3: 1.
preferably, the solvent in step 3) is DMF, and the solvent in the piperidine solution is also DMF; the catalyst is Diisopropylethylamine (DIEA).
Preferably, the mass ratio of the aldehyde dextran, the adipic acid dihydrazide and the partially alkylated dextran solution in the step 4) is (2-4):1: 1.
Preferably, the ratio of the polypeptide to the aldehyde dextran solution in step 4) is 1 μ g: 200 μ L.
The partially alkylated dextran is synthesized by reacting the aldehyde dextran with fatty amine. The polypeptides that promote fibroblast migration are synthesized by solid phase synthesis (polypeptides vary depending on the kind and number of amino acids and the order of arrangement). The aldehyde dextran, the dihydrazide and the alkyl modified dextran are respectively dissolved in a PBS solution, mixed according to a certain mass ratio, and preloaded with the novel polypeptide synthesized by the solid phase, so as to prepare the injectable dynamic self-repairing antibacterial hydrogel dressing preloaded with the polypeptide. The aldehyde groups of the partially alkylated dextran react with the amino groups of the dihydrazide, increasing the degree of crosslinking of the hydrogel. The novel polypeptide can promote the migration of fiber cells to stimulate wound healing and provide wound healing promotion performance for the hydrogel dressing. Preloaded solid-phase synthesized polypeptides, belonging to the preloaded type, are convenient to release.
The product obtained by the reaction of the aldehyde dextran and the fatty amine can improve the tissue adhesion performance of the hydrogel.
The strength of the self-repairing hydrogel is controlled by regulating the content ratio of the aldehyde dextran, the partially alkylated dextran and the bisamide.
The invention provides an injectable dynamic self-repairing antibacterial hydrogel dressing preloaded with polypeptides, which has good antibacterial performance, can reduce the infection chance of wounds, has dynamic self-repairing performance, can aim at irregular wounds, can keep the wound surfaces moist and accelerate the wound healing.
Compared with the existing hydrogel dressing, the hydrogel dressing has the beneficial effects that:
(1) the macromolecular monomer adopted by the invention is glucan which is proved to have excellent biocompatibility and biodegradability and can be used as a self-repairing biological material for promoting wound healing. The glucan can activate macrophages, thereby stimulating the increase of epidermal growth factors and improving the regeneration capacity of wound skin cells.
(2) According to the invention, through the acylhydrazone bond crosslinking reaction, redundant initiators are not required to be introduced, so that the toxicity of the reagent is reduced, and the safety of the prepared product is improved.
(3) The product obtained by the invention has dynamic self-repairing performance, the acylhydrazone bond is generated to quickly form gel in an injection mode, and the fractured hydrogel is automatically and dynamically repaired at the same time, so that the service time of the hydrogel is prolonged, the times of dressing change are reduced, and the healing of irregular wounds is facilitated.
(4) The alkyl chain of the partially alkylated glucan adopted by the invention is inserted into and anchored in the lipid bilayer of the cell membrane, so that the hydrogel dressing has a tissue adhesion function.
(5) The novel polypeptide prepared by the invention has good biocompatibility, and can accelerate wound healing by promoting the migration of fibroblasts, keratinocytes and vascular endothelial cells.
(6) The product prepared by the invention has good antibacterial performance, can reduce the infection chance of wounds, has dynamic self-repairing performance, can aim at irregular wounds, can keep the wound surfaces moist and accelerate the wound healing.
Drawings
FIG. 1 is a schematic of the synthesis of an aldehyde-based dextran;
FIG. 2 is a schematic of the synthesis of modified glucan;
fig. 3 is a flow chart of a method for preparing the dynamic self-repairing hydrogel dressing.
Detailed Description
In order to make the invention more comprehensible, preferred embodiments are described in detail below with reference to the accompanying drawings.
Example 1
A preparation method of an injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptides comprises the following steps:
a) preparation of aldehyde dextran:
dextran (formula 1 in figure 1) (6g) with number average molecular weight of 10000 is dissolved in 100mL deionized water at room temperature, sodium periodate (2g) is dissolved in 5mL deionized water, sodium periodate solution is added into the dextran solution drop by drop, reaction is carried out for 6 hours under the condition of keeping out of the sun, glycol (2g) is added for reaction for 1 hour at room temperature, the obtained product (formula 2 in figure 1) is dialyzed for one week, freeze-dried and stored at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixture, stirring for 18 hours at room temperature, precipitating partially alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing, lyophilizing, and storing at low temperature.
c) Solid phase preparation of polypeptide:
2g of dichlorotrityl chloride resin is taken to a polypeptide synthesis device, 20mL of dry DMF is added for soaking for half an hour to fully swell the resin, and finally the solvent DMF is discharged.
0.25g of amino acid was weighed and dissolved in DMF, and the solution was transferred to the above apparatus for peptide synthesis containing the treated resin, 2mL of Diisopropylethylamine (DIEA) as a catalyst was added, and the amino acid and the resin were allowed to interact for 1.5 hours at room temperature to sufficiently immobilize the amino acid on the resin.
The resin was washed with DMF.
20mL of 20 wt% piperidine/DMF solution was added to the resin in the previous step and reacted for half an hour to remove the protecting group.
The resin was washed with DMF and checked for complete protection with ninhydrin.
1.43g amino acid, 2.37g HBTU, 0.84g HOBt were weighed and dissolved in DMF, and the solution was transferred to the above apparatus for peptide synthesis containing treated resin, and 2mL of DIEA catalyst was added and reacted at room temperature for 1.5 hours.
The resin was washed with DMF. The completion of the amino group reaction was checked with ninhydrin. If the product is colorless, the condensation reaction can be carried out for the next step; if blue color is developed, the reaction solution is condensed to colorless, and then the next operation can be carried out.
The above steps are repeated until the desired polypeptide is synthesized.
The resin was washed with dichloromethane, thoroughly dried and dried in a vacuum oven for 24 hours.
The dried product was reacted with trifluoroacetic acid (20mL) for 2 hours to cleave the polypeptide.
Collecting filtrate and washing liquid, rotary evaporating for concentration, precipitating with anhydrous ether, and standing for a period of time. And after the precipitation is sufficient, carrying out suction filtration, washing and drying.
d) Preparation of injectable dynamic self-repairing antibacterial hydrogel dressing preloaded with polypeptide:
dissolving aldehyde dextran (structural formula 2 in figure 1), adipic acid dihydrazide and partially alkylated dextran (structural formula 4 in figure 2) in PBS buffer solution respectively, mixing according to the mass ratio of 3:1:1, preloading a trace amount of polypeptide synthesized by a solid phase (the ratio of the polypeptide to the aldehyde dextran solution is 1 mug: 200 muL), and preparing injectable dynamic self-repairing antibacterial hydrogel preloaded with the polypeptide;
e) the injectable self-repairing antibacterial hydrogel preloaded with the polypeptide is combined with non-woven fabrics or cotton fabrics to prepare the dressing.
Example 2
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (2g) in 5mL deionized water, dropwise adding sodium periodate solution into dextran solution, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for one week, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 3
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 100000 in 100mL deionized water at room temperature, dissolving sodium periodate (2g) in 5mL deionized water, adding sodium periodate solution into dextran solution dropwise, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for one week, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 4
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving potassium periodate (2g) in 5mL deionized water, adding potassium periodate solution into dextran solution dropwise, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for one week, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 5
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving potassium permanganate (1g) in 5mL deionized water, dropwise adding potassium permanganate solution into dextran solution, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for 3 days, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 6
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (2g) in 5mL deionized water, dropwise adding sodium periodate solution into dextran solution, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for one week, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving tetradecylamine (0.1g) in ethanol solution, adding tetradecylamine solution into aldehyde dextran (formula 2 in figure 1), reacting for 2 hr, adding excessive sodium cyanoborohydride (0.1g) into the mixture, stirring at room temperature for 18 hr, precipitating partially alkylated dextran with ethanol, dialyzing the reaction product, lyophilizing, and storing at low temperature.
Example 7
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (2g) in 5mL deionized water, dropwise adding sodium periodate solution into dextran solution, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for one week, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving pentadecamine (0.1g) in ethanol solution, adding pentadecamine solution into aldehyde dextran (formula 2 in figure 1), reacting for 2 hr, adding excessive sodium cyanoborohydride (0.1g) into the mixture, stirring at room temperature for 18 hr, precipitating part of alkylated dextran with ethanol, dialyzing the reaction product, freeze drying, and storing at low temperature.
Example 8
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (4g) in 5mL deionized water, adding sodium periodate solution into dextran solution dropwise, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for 3 days, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (0.1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 9
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (4g) in 5mL deionized water, adding sodium periodate solution into dextran solution dropwise, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for 3 days, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (0.1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating partially alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.
Example 10
The preparation method of the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptide is different from that of the example 1 in that:
the step a) is as follows:
the step a) is as follows:
a) preparation of aldehyde dextran:
dissolving dextran (formula 1 in figure 1) (6g) with number average molecular weight of 50000 in 100mL deionized water at room temperature, dissolving sodium periodate (4g) in 5mL deionized water, adding sodium periodate solution into dextran solution dropwise, reacting for 6 hours under dark condition, adding ethylene glycol (2g) to react for 1 hour at room temperature, dialyzing the obtained product (formula 2 in figure 1) for 3 days, freeze-drying, and storing at low temperature.
b) Preparation of modified glucan:
dissolving aldehyde dextran (1g) in deionized water at room temperature, dissolving dodecylamine (1g) in ethanol solution, adding dodecylamine (structure formula 3 in figure 2) solution into aldehyde dextran (structure formula 2 in figure 1) solution, reacting for 2 hours, adding excessive sodium cyanoborohydride (1g) into the mixed solution, stirring for 18 hours at room temperature, precipitating part of alkylated dextran (structure formula 4 in figure 2) with ethanol, dialyzing the reaction product, freeze-drying, and storing at low temperature.

Claims (9)

1. The injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides is characterized by comprising a hydrogel combined with a fabric, wherein the surface and the inside of the hydrogel are distributed with the polypeptides capable of promoting migration of fiber cells; the hydrogel is prepared by respectively dissolving aldehyde dextran, dihydrazide and partially alkylated dextran in PBS solution, mixing and crosslinking; the partially alkylated glucan is prepared by the following method: dissolving aldehyde dextran in deionized water at room temperature, dissolving fatty amine in ethanol solution, mixing the two solutions, and reacting for 1-4 hours; adding excessive sodium cyanoborohydride into the mixed solution, stirring at room temperature for 12-24 hours, and precipitating part of alkylated glucan by using ethanol; and dialyzing, freeze-drying and storing the reaction product.
2. The injectable self-healing antimicrobial hydrogel dressing preloaded with polypeptides of claim 1, wherein said polypeptides contain a KGRT sequence derived from erythroid differentiation regulating factor 1, a functional region of Erdr1, sharing three amino acids with Erdr1, wherein Erdr1 modulates stress-related responses.
3. The injectable self-healing antimicrobial hydrogel dressing preloaded with polypeptides of claim 1, wherein the molar ratio of sodium cyanoborohydride to aldehydized dextran is 3: 1.
4. the method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides in the claim 1 or 2, is characterized by comprising the following steps:
step 1): selectively oxidizing glucans with different molecular weights into aldehyde group glucan by an oxidant;
step 2): reacting the aldehyde dextran with fatty amine to obtain partially alkylated dextran;
step 3): solid phase preparation of polypeptide:
step 3.1): adding dichlorotrityl chloride resin into a solvent for soaking, fully swelling the resin, and then discharging the solvent;
step 3.2): dissolving amino acid with solvent, transferring the solution into treated dichloro trityl chloride resin, adding catalyst, and allowing the amino acid and resin to interact at room temperature to fix on the resin;
step 3.3): washing the resin with a solvent, adding a piperidine solution into the resin for reaction, and removing a protecting group;
step 3.4): the resin was washed with solvent and checked for complete protection with ninhydrin;
step 3.5): dissolving amino acid, HBTU and HOBt in a solvent, transferring the solution into the resin obtained in the step 3.4), adding a catalyst, and reacting at room temperature; washing the resin with a solvent, checking whether the amino group is completely reacted with ninhydrin, and carrying out the next step if the amino group is colorless; if the color is blue, repeating the step until the color is detected to be colorless, and synthesizing the polypeptide;
step 3.6): washing the resin with dichloromethane, fully washing to dry, and then drying;
step 3.7): reacting trifluoroacetic acid with the product obtained in the step 3.6) to cut off polypeptide;
step 3.8): collecting filtrate and washing liquid, performing rotary evaporation and concentration, precipitating with anhydrous ether, and standing; after the precipitation is sufficient, carrying out suction filtration, washing and drying;
step 4): dissolving the aldehyde dextran obtained in the step 1), adipic acid dihydrazide and the partially alkylated dextran obtained in the step 2) in a PBS buffer solution respectively, adding the polypeptide prepared in the step 3) into the aldehyde dextran solution, preloading the polypeptide synthesized in a solid phase, and then mixing the three solutions to prepare the injectable self-repairing antibacterial hydrogel preloaded with the polypeptide;
step 5): the injectable self-repairing antibacterial hydrogel preloaded with the polypeptide is combined with the fabric to prepare the dressing.
5. The method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides as claimed in claim 4, wherein the number average molecular weight of the glucan in the step 1) is 5000-100000; the oxidant is KMnO4,NaIO4Or KIO4
6. The method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides in claim 4, wherein the number of carbon atoms of the aliphatic amine in the step 2) is 6-15.
7. The method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides as claimed in claim 4, wherein a solvent in the step 3) is DMF, and a solvent in a piperidine solution is also DMF; the catalyst is diisopropylethylamine.
8. The method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides as claimed in claim 4, wherein the mass ratio of the aldehyde dextran, the adipic acid dihydrazide and the partially alkylated dextran solution in the step 4) is (2-4) to 1: 1.
9. The method for preparing the injectable self-repairing antibacterial hydrogel dressing preloaded with the polypeptides according to claim 4, wherein the ratio of the polypeptides to the aldehyde dextran solution in the step 4) is 1 μ g: 200 μ L.
CN202010250210.1A 2020-04-01 2020-04-01 Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof Active CN111388741B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010250210.1A CN111388741B (en) 2020-04-01 2020-04-01 Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010250210.1A CN111388741B (en) 2020-04-01 2020-04-01 Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111388741A CN111388741A (en) 2020-07-10
CN111388741B true CN111388741B (en) 2021-09-07

Family

ID=71417421

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010250210.1A Active CN111388741B (en) 2020-04-01 2020-04-01 Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111388741B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115844927B (en) * 2023-03-02 2023-05-12 深圳汉盛再生医学科技有限公司 Application of stem cells in preparation of preparation for treating leukoencephalopathy

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101111272A (en) * 2005-01-31 2008-01-23 Bmg株式会社 Self-degradable two-component reactive adhesive for medical use and resin for medical use
CN101405028A (en) * 2006-03-17 2009-04-08 美国政府健康及人类服务部 Methods for preparing complex multivalent immunogenic conjugates
CN101541857A (en) * 2006-11-27 2009-09-23 纳幕尔杜邦公司 Multi-functional polyalkylene oxide, hydrogel tissue adhesives
JP4524365B2 (en) * 2004-02-25 2010-08-18 財団法人名古屋産業科学研究所 Method for producing asymmetric aliphatic tertiary amine
US8431114B2 (en) * 2004-10-07 2013-04-30 Actamax Surgical Materials, Llc Polysaccharide-based polymer tissue adhesive for medical use
CN103261146A (en) * 2010-12-17 2013-08-21 Sika技术股份公司 Polyamines having secondary aliphatic amino groups
CN103611181A (en) * 2013-10-25 2014-03-05 无锡灵锡医疗器械科技有限公司 Antibacterial peptide hydrogel and preparation method thereof
CN103788211A (en) * 2012-11-01 2014-05-14 中国科学院上海药物研究所 Bifunctional peptide, composite formed by the bifunctional peptide and nucleic acid molecule, and pharmaceutical composite used for treating tumor
CN105348548A (en) * 2015-10-27 2016-02-24 昆明理工大学 Hydrogel microspheres based on glucan and preparation method thereof
CN105708792A (en) * 2016-01-28 2016-06-29 山西普德药业股份有限公司 Reduced carboxy alkyl dextriferron injection and preparation method thereof
CN106039382A (en) * 2016-05-25 2016-10-26 东华大学 Glucan-based transparent hydrogel dressing and preparation method thereof
CN106620825A (en) * 2016-12-26 2017-05-10 浙江大学 Bi-component quick haemostatic gel and application thereof
CN110894302A (en) * 2019-11-19 2020-03-20 福建医科大学孟超肝胆医院(福州市传染病医院) Antibacterial hydrogel based on imine bond and acylhydrazone bond and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2195039T3 (en) * 2007-08-28 2017-01-30 Otago Innovation Ltd SURGICAL HYDROGEL

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4524365B2 (en) * 2004-02-25 2010-08-18 財団法人名古屋産業科学研究所 Method for producing asymmetric aliphatic tertiary amine
US8431114B2 (en) * 2004-10-07 2013-04-30 Actamax Surgical Materials, Llc Polysaccharide-based polymer tissue adhesive for medical use
CN101111272A (en) * 2005-01-31 2008-01-23 Bmg株式会社 Self-degradable two-component reactive adhesive for medical use and resin for medical use
CN101405028A (en) * 2006-03-17 2009-04-08 美国政府健康及人类服务部 Methods for preparing complex multivalent immunogenic conjugates
CN101541857A (en) * 2006-11-27 2009-09-23 纳幕尔杜邦公司 Multi-functional polyalkylene oxide, hydrogel tissue adhesives
CN103261146A (en) * 2010-12-17 2013-08-21 Sika技术股份公司 Polyamines having secondary aliphatic amino groups
CN103788211A (en) * 2012-11-01 2014-05-14 中国科学院上海药物研究所 Bifunctional peptide, composite formed by the bifunctional peptide and nucleic acid molecule, and pharmaceutical composite used for treating tumor
CN103611181A (en) * 2013-10-25 2014-03-05 无锡灵锡医疗器械科技有限公司 Antibacterial peptide hydrogel and preparation method thereof
CN105348548A (en) * 2015-10-27 2016-02-24 昆明理工大学 Hydrogel microspheres based on glucan and preparation method thereof
CN105708792A (en) * 2016-01-28 2016-06-29 山西普德药业股份有限公司 Reduced carboxy alkyl dextriferron injection and preparation method thereof
CN106039382A (en) * 2016-05-25 2016-10-26 东华大学 Glucan-based transparent hydrogel dressing and preparation method thereof
CN106620825A (en) * 2016-12-26 2017-05-10 浙江大学 Bi-component quick haemostatic gel and application thereof
CN110894302A (en) * 2019-11-19 2020-03-20 福建医科大学孟超肝胆医院(福州市传染病医院) Antibacterial hydrogel based on imine bond and acylhydrazone bond and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Controlling the degradation of an oxidized dextran-based hydrogel independent of the mechanical properties;Punnida Nonsuwan等;《Carbohydrate Polymers》;20190115;第204卷(第15期);第131-141页 *
Dextran-based materials for biomedical applications;J.Maia等;《Carbohydrate Applications in Medcine》;20140131;第31-53页 *
Erthroid differentiation regulator 1( Erdr1) enhances wound healing through collagen synthesis in acen skin;Eun-Yeung Gong等;《Archives of Dermatological Research》;20200131;第1-9页 *
一种新型葡聚糖基水凝胶敷料的制备及其性质;吴飞飞等;《东华大学学报(自然科学版)》;20180309;第43卷(第6期);第861-868页 *
基于醛基葡聚糖的海绵材料制备及性能研究;郑策等;《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》;20190827;第B016-286页 *
多糖的化学修饰对其生物活性影响研究进展;孟思彤等;《天然产物研究与开发》;20141231;第1901-1905页 *

Also Published As

Publication number Publication date
CN111388741A (en) 2020-07-10

Similar Documents

Publication Publication Date Title
Du et al. Injectable hydrogel composed of hydrophobically modified chitosan/oxidized-dextran for wound healing
Ye et al. Self-healing pH-sensitive cytosine-and guanosine-modified hyaluronic acid hydrogels via hydrogen bonding
EP0918548B1 (en) Use of oxidized cellulose and complexes thereof for chronic wound healing
JP3094074B2 (en) Polysaccharide gel composition
JP4662948B2 (en) Wound care products containing keratin
EP1316321B1 (en) Base materials for tissue regeneration, transplant materials and process for producing the same
CN111840631A (en) Injectable antibacterial hemostatic hydrogel adhesive and preparation method and application thereof
CN109106977B (en) Self-healing injectable hydrogel dressing for diabetic wound repair and preparation method and application thereof
CN113209363B (en) Adhesive hemostasis injectable chitosan gel and preparation method and application thereof
CN113368312B (en) Preparation method and application of biodegradable self-adhesive hydrogel
CN113372585A (en) Preparation method and application of hydrogel with high-adhesion composite function
CN109157669B (en) Cellulose-reinforced glucan-based injectable antibacterial hydrogel dressing and preparation method thereof
CN113425893A (en) Preparation method and application of drug-loaded hydrogel
CN111388741B (en) Injectable self-repairing antibacterial hydrogel dressing preloaded with polypeptide and preparation method thereof
CN111303452A (en) Bionic antibacterial high-adhesion double-network hydrogel and preparation method and application thereof
Wei et al. Injectable poly (γ-glutamic acid)-based biodegradable hydrogels with tunable gelation rate and mechanical strength
CN113730577A (en) Schiff base water gel material with phenylboronic acid grafted on side chain and active oxygen eliminating function and preparation method thereof
CN108525003A (en) Based on the double cross of acylhydrazone key and hydrophobe self assembly connection hybridized hydrogel, preparation method and skin histology wound repair agent
CN105801870B (en) The preparation method and products obtained therefrom of a kind of poly sialic acid-hyaluronic acid plural gel and application
CN113144275B (en) Hydrogel adhesive and preparation method and application thereof
CN113354803B (en) Polycarbonate/polyethylene glycol block copolymer containing aldehyde side group, injectable self-repairing hydrogel dressing and preparation method
CN115337446A (en) Preparation method of bio-based adhesive hydrogel patch for promoting wound healing, product and application thereof
CN113388049A (en) Macromolecular derivative, preparation method thereof and application thereof in biological tissue adhesive
CN116036361B (en) Injection hydrogel and preparation method and application thereof
CN111187443B (en) Collagen-sodium humate compound suitable for hemostatic material and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant